GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Cyclically Adjusted Revenue per Share

Laboratorio Reig Jofre (XMAD:RJF) Cyclically Adjusted Revenue per Share : €3.63 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Laboratorio Reig Jofre's adjusted revenue per share for the three months ended in Dec. 2023 was €1.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.63 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Laboratorio Reig Jofre's average Cyclically Adjusted Revenue Growth Rate was 4.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Laboratorio Reig Jofre was 6.80% per year. The lowest was 2.40% per year. And the median was 4.60% per year.

As of today (2024-05-15), Laboratorio Reig Jofre's current stock price is €2.82. Laboratorio Reig Jofre's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €3.63. Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio of today is 0.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Laboratorio Reig Jofre was 2.07. The lowest was 0.60. And the median was 0.79.


Laboratorio Reig Jofre Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Laboratorio Reig Jofre's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Cyclically Adjusted Revenue per Share Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.23 2.98 3.20 3.47 3.63

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 3.47 - 3.58 3.63

Competitive Comparison of Laboratorio Reig Jofre's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio falls into.



Laboratorio Reig Jofre Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laboratorio Reig Jofre's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1/121.2698*121.2698
=1.000

Current CPI (Dec. 2023) = 121.2698.

Laboratorio Reig Jofre Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 0.413 100.597 0.498
201312 0.369 101.306 0.442
201403 2.483 100.139 3.007
201406 -1.404 101.081 -1.684
201409 5.817 100.441 7.023
201412 -1.271 100.251 -1.537
201503 0.683 99.474 0.833
201506 0.606 101.138 0.727
201509 0.594 99.559 0.724
201512 0.647 100.268 0.783
201603 0.673 98.638 0.827
201606 0.651 100.333 0.787
201609 0.569 99.737 0.692
201612 0.666 101.842 0.793
201703 0.696 100.896 0.837
201706 0.642 101.848 0.764
201709 0.553 101.524 0.661
201712 0.758 102.975 0.893
201803 0.729 102.122 0.866
201806 0.683 104.165 0.795
201809 0.667 103.818 0.779
201812 0.728 104.193 0.847
201903 0.764 103.488 0.895
201906 0.575 104.612 0.667
201909 0.718 103.905 0.838
201912 0.702 105.015 0.811
202003 0.820 103.469 0.961
202006 0.711 104.254 0.827
202009 0.723 103.521 0.847
202012 0.783 104.456 0.909
202103 0.815 104.857 0.943
202106 0.708 107.102 0.802
202109 0.743 107.669 0.837
202112 0.822 111.298 0.896
202206 0.000 118.044 0.000
202209 0.808 117.221 0.836
202212 0.978 117.650 1.008
202306 0.000 120.278 0.000
202309 1.032 121.343 1.031
202312 1.000 121.270 1.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Laboratorio Reig Jofre  (XMAD:RJF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Laboratorio Reig Jofre's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.82/3.63
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Laboratorio Reig Jofre was 2.07. The lowest was 0.60. And the median was 0.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Laboratorio Reig Jofre Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry
Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.